MedTrace Logo

Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland

NCT04823182 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-09-24

No results posted yet for this study

Summary

SETANTA study will investigate the incidence of cardiac abnormalities as assessed by cardiac magnetic resonance imaging in unselected patients after acute SARS-CoV-2 infection and correlation with immunological response and biomarkers of coagulation.

Conditions

  • SARS-CoV Infection
  • Covid19
  • Cardiomyopathies

Interventions

DIAGNOSTIC_TEST

Cardiovascular Magnetic Resonance Imaging

The Cardiac MRI protocol consists of static T2 weighted in all three planes and T2 weighted imaging with fat saturation in the short axis plane.

Sponsors & Collaborators

  • Cardiovascular Research Institute Dublin

    lead OTHER

Principal Investigators

  • Robert A Byrne, MB BCh PhD · CVRI Dublin at Mater Private Hospital

  • Roisin Colleran, MB BCh · CVRI Dublin at Mater Private Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-16
Primary Completion
2021-09-22
Completion
2022-09-22

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04823182 on ClinicalTrials.gov